CN105250481A - Medicine composition for treatment of blood stasis and preparation method and application thereof - Google Patents
Medicine composition for treatment of blood stasis and preparation method and application thereof Download PDFInfo
- Publication number
- CN105250481A CN105250481A CN201510763129.2A CN201510763129A CN105250481A CN 105250481 A CN105250481 A CN 105250481A CN 201510763129 A CN201510763129 A CN 201510763129A CN 105250481 A CN105250481 A CN 105250481A
- Authority
- CN
- China
- Prior art keywords
- radix
- pharmaceutical composition
- preparation
- blood stasis
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicine composition for treatment of blood stasis and a preparation method and application thereof. The medicine composition for treatment of blood stasis is mainly prepared from, by weight, 5-25 parts of rhizome of rehmannia, 4-22 parts of flos carthami, 4-20 parts of panax notoginseng, 4-25 parts of radix arnebiae and 3-25 parts of angelica sinensis. The medicine composition achieves compatibility of various sorts of traditional Chinese medicine, and the effects of promoting blood circulation to remove blood stasis, nourishing blood and cooling blood can be achieved.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of treat blood stasis pharmaceutical composition, its preparation method and application.
Background technology
Blood stasis refers to a kind of pattern of syndrome in Chinese medical discrimination.Blood stasis and blood operation are not smooth, have blood stasis.Blood stasis is found in a variety of disease.Generally speaking, all leave through feeling pulse blood can not dissipate in time and the stasis of blood stagnant in certain, or thrombosis, operation is obstructed, and to pool within passages through which vital energy circulates or organ in the state of stagnating, is all blood stasis.
The general performance of blood stasis has: skin is everlasting and is occurred purple ecchymosis (subcutaneous hemorrhage) unconsciously, and skin is normal dry, coarse, occurs pain; Dim complexion or have pigmentation, yellowish-brown speckle, the frequent darkness of eye socket, eyes often have red filament, and when brushing teeth, gingiva is easily hemorrhage; Easy agitation, forgetful, irascible temperament.
At present, be still of no curative effect on the market, the Chinese medicine preparation of effect stability.
Summary of the invention
In order to solve the problems referred to above that prior art exists, the invention provides a kind of treat blood stasis pharmaceutical composition, its preparation method and application.Described pharmaceutical composition adopts plurality of Chinese to carry out compatibility, can play blood circulation promoting and blood stasis dispelling, the effect of the removing heat from blood that nourishes blood.
The technical solution adopted in the present invention is: a kind of pharmaceutical composition for the treatment of blood stasis, and the raw material mainly comprising following weight portion is made: Radix Rehmanniae 5-25 part, Flos Carthami 4-22 part, Radix Notoginseng 4-20 part, Radix Arnebiae (Radix Lithospermi) 4-25 part, Radix Angelicae Sinensis 3-25 part.
Select as one of the present invention, a kind of pharmaceutical composition for the treatment of blood stasis, the raw material mainly comprising following weight portion is made: Radix Rehmanniae 10-20 part, Flos Carthami 8-18 part, Radix Notoginseng 8-16 part, Radix Arnebiae (Radix Lithospermi) 10-19 part, Radix Angelicae Sinensis 10-18 part.
Certainly, in order to reach better drug effect, preferred raw material and proportioning are that a kind of pharmaceutical composition for the treatment of blood stasis, the raw material mainly comprising following weight portion is made: 15 parts, the Radix Rehmanniae, 13 parts, Flos Carthami, Radix Notoginseng 12 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Radix Angelicae Sinensis 14 parts.
Present invention also offers the preparation method of the pharmaceutical composition of described treatment blood stasis, comprise the following steps:
A, Flos Carthami and Radix Arnebiae (Radix Lithospermi) added pure water and decoct distillation, discard medicinal residues, collect distillate;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, as medicated powder after sieving;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor;
D, described medicated powder added in decoction liquor decoct, as material liquid;
E, until described material liquid in the pasty state time, carry out receipts cream, vacuum drying, pulverization process successively, obtain granular pharmaceutical composition.
Through described preparation method, Chinese herbal medicine can be made granular pharmaceutical composition, easy to use.
By the extracts active ingredients in raw material out preferred technical scheme is in order to abundant, and the operation decocting distillation in step a repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:6-9.
In order to further facilitate the extraction to effective ingredient in raw material, preferred technical scheme is, the raw material in step a, before carrying out first time decoction distillation, first uses pure water to soak 3-5 hour.
According to physicochemical property and the active ingredient of the Radix Rehmanniae, to the decoction of the Radix Rehmanniae in different ways: in step c, the mass ratio of the Radix Rehmanniae and pure water is 1:10-15, and decocting time is 4-8 hour; In order to further facilitate the extraction to effective ingredient in raw material, powder described in step b crosses 80-100 mesh sieve.
Use for the convenience of the users, preferred technical scheme is, the particle diameter of described granular pharmaceutical composition is 200-280 μm.
In order to improve the mouthfeel of described pharmaceutical composition, preferred technical scheme is, boils in process in steps d, adds 3-5 part Mel.
The invention also discloses the application of pharmaceutical composition in preparation treatment blood stasis medicine of above-mentioned treatment blood stasis.Described treatment blood stasis medicine includes but are not limited to all kinds of Chinese medicine preparation, medicated tea, adhesive plaster etc.Such as described Chinese medicine preparation can make tablet, suspending agent, granule, spray, stick agent etc.But as preferably, pharmaceutical composition of the present invention is applied to the medicated tea making treatment blood stasis.
For the ease of understanding the present invention, below the raw material in the present invention and drug effect are further elaborated.
The Radix Rehmanniae, Classification system: RehmanniaglutinosaLibosch, sweet-bitter flavor, cold in nature and enter blood system, clearing away heat and cooling blood.Cure mainly fever due to yin deficiency, quench one's thirst, spit blood, epistaxis, metrorrhagia, menoxenia, frequent fetal movement, the moon hinders constipation.
Flos Carthami is the dried floral of feverfew Flos Carthami CarthamustinctoriusL..Flos Carthami is warm in nature, acrid in the mouth, cures mainly latus rectum of invigorating blood circulation, eliminating stasis to stop pain.For amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury.
Radix Notoginseng is the dry root welding technology of panax araliaceae plant Panaxnotoginseng (Burk.) F.H.Chen.Sweet, the micro-hardship of Radix Notoginseng, temperature, returns liver, stomach warp, hemostasis, dissipating blood stasis, detumescence, analgesic therapy, and treatment is spitted blood, and hemoptysis, epistaxis, has blood in stool, dysentery, metrorrhagia ， mass in the abdomen, puerperal blood faints, and retention of lochia, falls and flutter blood stasis, traumatic hemorrhage, carbuncle pain.
Radix Arnebiae (Radix Lithospermi), formal name used at school: Lithospermumerythrorhizon, Radix Arnebiae (Radix Lithospermi) bitter in the mouth, cold in nature, there is heat clearing away cooling, effect of removing heat from blood rash, contain for heat in blood poison, macule purple is black, measles without adequate eruption, skin infection, eczema, burn due to hot liquid or fire.Clearing away heat and cooling blood, for measles, calentura skin eruption, eczema, hematuria, stranguria with blood, dysentery, skin infection, erysipelas, burn, constipation with heat retention.
Radix Angelicae Sinensis, Classification system Angelicasinensis (Oliv.) Diels, perennial herb, high 0.4-1 rice.Root is cylindric, branch, has most meat fibrous root, yellowish-brown, has strong fragrance.Stem is upright, and green white or band purple, have depth rill, Glabrous.Inventor thinks, Radix Angelicae Sinensis sweet in the mouth and weighing, therefore specially can enrich blood, and its gas is light and pungent, therefore again can promoting the circulation of blood, and invigorating middle warmer has, and having benefit in row, is the key medicine in blood.Thus, it can be enriched blood, and can invigorate blood circulation again, both can stimulate the menstrual flow, again can be active.
The Fang Xiewei of the pharmaceutical composition in the present invention: the present invention is with the Flos Carthami of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain for monarch drug, and the Radix Notoginseng of blood-supplementing blood-nourishing, blood circulation promoting and blood stasis dispelling, removing heat from blood, invigorate blood circulation, the Radix Arnebiae (Radix Lithospermi) of removing toxic substances rash is ministerial drug, and the Radix Rehmanniae of clearing away heat and cooling blood is adjuvant drug, can enrich blood, can invigorate blood circulation again, both can stimulate the menstrual flow, again can be active ought be classified as makes medicine, full side can invigorate blood circulation, can enrich blood again, both can nourish blood, the dryness-fire in blood can be moistened again, compatibility is reasonable, is the more effective good side for the treatment of blood stasis body constitution, good recipe.
Beneficial effect of the present invention is:
1, the invention provides a kind of pharmaceutical composition for the treatment of blood stasis, there is blood circulation promoting and blood stasis dispelling, the effect of the removing heat from blood that nourishes blood.
2, the invention provides a kind of preparation method of described pharmaceutical composition, have step simple to operation, material effective component loses little advantage.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further elaborated.
Embodiment 1
Treat a pharmaceutical composition for blood stasis, the raw material comprising following weight is made: Radix Rehmanniae 5g, Flos Carthami 22g, Radix Notoginseng 4g, Radix Arnebiae (Radix Lithospermi) 25g, Radix Angelicae Sinensis 3g.
A preparation method for described pharmaceutical composition, comprises the following steps:
A, first use pure water to soak 3 hours on Flos Carthami and Radix Arnebiae (Radix Lithospermi), carry out decoction distillation after having soaked, discard medicinal residues, collect distillate; The operation decocting distillation repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:6;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, to cross after 80 mesh sieves as medicated powder;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor; The weight ratio of the described Radix Rehmanniae and pure water is 1:10, and decocting time is 4 hours;
D, described medicated powder added in decoction liquor decoct, when decoction liquor in the pasty state time, add described distillate and 3g Mel continues to boil, as material liquid;
E, by described material liquid successively through receiving cream, vacuum drying, pulverization process become particle diameter to be 240 μm of granules, by described granule bag distribution packaging, in bag distribution packaging, in every bag, the quality of granule is 50g.
Embodiment 2
Treat a pharmaceutical composition for blood stasis, the raw material comprising following weight is made: Radix Rehmanniae 25g, Flos Carthami 4g, Radix Notoginseng 20g, Radix Arnebiae (Radix Lithospermi) 4g, Radix Angelicae Sinensis 25g.
A preparation method for described pharmaceutical composition, comprises the following steps:
A, first use pure water to soak 5 hours on Flos Carthami and Radix Arnebiae (Radix Lithospermi), carry out decoction distillation after having soaked, discard medicinal residues, collect distillate; The operation decocting distillation repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:9;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, to cross after 100 mesh sieves as medicated powder;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor; The weight ratio of the described Radix Rehmanniae and pure water is 1:15, and decocting time is 8 hours;
D, described medicated powder added in decoction liquor decoct, when decoction liquor in the pasty state time, add described distillate and 5g Mel continues to boil, as material liquid;
E, by described material liquid successively through receiving cream, vacuum drying, pulverization process become particle diameter to be 200 μm of granules, by described granule bag distribution packaging, in bag distribution packaging, in every bag, the quality of granule is 100g.
Embodiment 3
Treat a pharmaceutical composition for blood stasis, the raw material comprising following weight is made: Radix Rehmanniae 15g, Flos Carthami 13g, Radix Notoginseng 12g, Radix Arnebiae (Radix Lithospermi) 15g, Radix Angelicae Sinensis 14g.
A preparation method for described pharmaceutical composition, comprises the following steps:
A, first use pure water to soak 4 hours on Flos Carthami and Radix Arnebiae (Radix Lithospermi), carry out decoction distillation after having soaked, discard medicinal residues, collect distillate; The operation decocting distillation repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:7;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, to cross after 90 mesh sieves as medicated powder;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor; The weight ratio of the described Radix Rehmanniae and pure water is 1:12, and decocting time is 6 hours;
D, described medicated powder added in decoction liquor decoct, when decoction liquor in the pasty state time, add described distillate and 4g Mel continues to boil, as material liquid;
E, by described material liquid successively through receiving cream, vacuum drying, pulverization process become particle diameter to be 280 μm of granules, by described granule bag distribution packaging, in bag distribution packaging, in every bag, the quality of granule is 75g.
Embodiment 4
Treat a pharmaceutical composition for blood stasis, the raw material comprising following weight is made: Radix Rehmanniae 10g, Flos Carthami 18g, Radix Notoginseng 8g, Radix Arnebiae (Radix Lithospermi) 19g, Radix Angelicae Sinensis 10g.
A preparation method for described pharmaceutical composition, comprises the following steps:
A, first use pure water to soak 3 hours on Flos Carthami and Radix Arnebiae (Radix Lithospermi), carry out decoction distillation after having soaked, discard medicinal residues, collect distillate; The operation decocting distillation repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:8;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, to cross after 80 mesh sieves as medicated powder;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor; The weight ratio of the described Radix Rehmanniae and pure water is 1:14, and decocting time is 5 hours;
D, described medicated powder added in decoction liquor decoct, when decoction liquor in the pasty state time, add described distillate and continue to boil, as material liquid;
E, by described material liquid successively through receiving cream, vacuum drying, pulverization process become particle diameter to be 220 μm of granules, by described granule bag distribution packaging, in bag distribution packaging, in every bag, the quality of granule is 65g.
Embodiment 5
Treat a pharmaceutical composition for blood stasis, the raw material comprising following weight is made: Radix Rehmanniae 20g, Flos Carthami 8g, Radix Notoginseng 16g, Radix Arnebiae (Radix Lithospermi) 10g, Radix Angelicae Sinensis 18g.
A preparation method for described pharmaceutical composition, comprises the following steps:
A, first use pure water to soak 5 hours on Flos Carthami and Radix Arnebiae (Radix Lithospermi), carry out decoction distillation after having soaked, discard medicinal residues, collect distillate; The operation decocting distillation repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:8;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, to cross after 80 mesh sieves as medicated powder;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor; The weight ratio of the described Radix Rehmanniae and pure water is 1:15, and decocting time is 7 hours;
D, described medicated powder added in decoction liquor decoct, when decoction liquor in the pasty state time, add described distillate and continue to boil, as material liquid;
E, by described material liquid successively through receiving cream, vacuum drying, pulverization process become particle diameter to be 260 μm of granules, by described granule bag distribution packaging, in bag distribution packaging, in every bag, the quality of granule is 80g.
The invention also discloses the application of described pharmaceutical composition in preparation treatment blood stasis medicine.In another embodiment of the present invention, use the pharmaceutical composition of any embodiment gained of the present invention, and be prepared into pill, tablet, granule, syrup, suspending agent, brew medicated tea etc.In another embodiment of the present invention, use the pharmaceutical composition of any embodiment gained of the present invention, help the medicine being made into treatment blood stasis with other adjuvants and/or Chinese herbal medicine.
Be below therapeutic test that pharmaceutical composition described in the present invention did:
(1), testing crew physical data
Select various blood stasis patient 270 examples through making a definite diagnosis, wherein skin is everlasting and is occurred purple ecchymosis (subcutaneous hemorrhage) unconsciously, skin is normal dry, coarse, there is pain person 90 example, dim complexion or have pigmentation, yellowish-brown speckle, the frequent darkness of eye socket, eyes often have red filament, gingiva easy bleeder 90 example when brushing teeth; Easy agitation, forgetful, irascible temperament person 90 example.In 270 routine patients, M-F is 1:1,18 ~ 74 years old age and in normal distribution, 44 years old mean age.
(2), testing crew diagnosis basis
With national higher medical institute teaching material " internal medicine " and " surgery " for standard, with data such as clinical manifestation, hospital diagnosis conclusion, B ultrasonic reports for foundation, carry out reference, get rid of Other diseases.
(3), test method
270 routine blood stasis patients are divided into three groups at random: treat one group, treat two groups and matched group.In three groups, the number of various blood stasis patient is identical, and the data no difference of science of statistics of age and sex in three groups.
Treat the pharmaceutical composition in one group of use embodiment 1; Treat two groups and use pharmaceutical composition in embodiment 3, treat one group and treatment two groups all according to according to conventional method decoction, sooner or later respectively once; Matched group uses pharmaceutical composition (10 grams, Radix Rehmanniae Preparata, Radix Codonopsis 15 grams, Rhizoma Atractylodis Macrocephalae (parched) 15 grams, Flos Inulae 10g, the Rhizoma Cyperi 10g for the treatment of blood stasis common on the market; Decoct according to conventional method and take).Take 30 days all continuously for three groups, if cure, stop using.
(4), curative effect determinate standard
Cure: clinical symptoms disappears completely, recover orthobiosis;
Effective: clinical symptoms partial disappearance, every sign progressively takes a turn for the better;
Invalid: symptom and sign is not improved;
Cure rate and effective percentage all count total effective rate.
(5), result of the test and conclusion
The experimental result for the treatment of one group is as shown in table 1
Table 1: the experimental result table for the treatment of a group
| Cure rate | Effective percentage | Total effective rate | Inefficiency | |
| Xerosis cutis | 70％ | 23.3％ | 93.3％ | 6.7％ |
| Dim complexion | 73.3％ | 16.7％ | 90％ | 10％ |
| Irascible temperament | 73.3％ | 16.7％ | 90％ | 10％ |
The experimental result for the treatment of two groups is as shown in table 2
Table 2: the experimental result table for the treatment of two groups
| Cure rate | Effective percentage | Total effective rate | Inefficiency | |
| Xerosis cutis | 73.3％ | 23.3％ | 96.7％ | 3.3％ |
| Dim complexion | 80％ | 16.7％ | 96.7％ | 3.3％ |
| Irascible temperament | 76.7％ | 2％ | 96.7％ | 3.3％ |
The experimental result of matched group is as shown in table 3
Table 3: the experimental result table of matched group
| Cure rate | Effective percentage | Total effective rate | Inefficiency | |
| Xerosis cutis | 40％ | 20％ | 60％ | 40％ |
| Dim complexion | 50％ | 10％ | 60％ | 40％ |
| Irascible temperament | 30％ | 20％ | 50％ | 50％ |
Conclusion: the cure rate 70%-80% of pharmaceutical composition provided by the invention, total effective rate is 90%-96.7%; Far above 30%-50% and 50%-60% of the pharmaceutical composition for the treatment of blood stasis common on the market; The excellent effect of pharmaceutical composition provided by the invention is described and stablizes.
(6), the concrete case of part:
Song, man 39 years old, blood stasis body constitution, takes pharmaceutical composition in the present invention 25 days, recovery from illness.
Hole, man, 31 years old, blood stasis body constitution, took pharmaceutical composition in the present invention 28 days, recovery from illness.
Liu, female, 29 years old, blood stasis body constitution for many years, gave the present invention through dialectical, took pharmaceutical composition in the present invention 20 days, recovery from illness.
Song, man, 39 years old, suffers from Blood stasis, after dialectical, give the present invention, and take pharmaceutical composition in the present invention 30 days, symptom fades away, and now fully recovers.
Huang, female, 54 years old, blood stasis body constitution for many years, take pharmaceutical composition in the present invention 30 days, progressively got well, transference cure by health, recovery from illness.
The present invention is not limited to above-mentioned preferred forms; anyone can draw other various forms of products under enlightenment of the present invention; no matter but any change is done in its shape or structure; every have identical with the application or akin technical scheme, all drops within protection scope of the present invention.
Claims (10)
1. treat a pharmaceutical composition for blood stasis, it is characterized in that, the raw material mainly comprising following weight portion is made: Radix Rehmanniae 5-25 part, Flos Carthami 4-22 part, Radix Notoginseng 4-20 part, Radix Arnebiae (Radix Lithospermi) 4-25 part, Radix Angelicae Sinensis 3-25 part.
2. the pharmaceutical composition for the treatment of blood stasis according to claim 1, is characterized in that, the raw material mainly comprising following weight portion is made: Radix Rehmanniae 10-20 part, Flos Carthami 8-18 part, Radix Notoginseng 8-16 part, Radix Arnebiae (Radix Lithospermi) 10-19 part, Radix Angelicae Sinensis 10-18 part.
3. the pharmaceutical composition for the treatment of blood stasis according to claim 1, is characterized in that, the raw material mainly comprising following weight portion is made: 15 parts, the Radix Rehmanniae, 13 parts, Flos Carthami, Radix Notoginseng 12 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, Radix Angelicae Sinensis 14 parts.
4., according to a preparation method for the arbitrary described pharmaceutical composition of claim 1-3, it is characterized in that, comprise the following steps:
A, Flos Carthami and Radix Arnebiae (Radix Lithospermi) added pure water and decoct distillation, discard medicinal residues, collect distillate;
B, by Radix Notoginseng, Radix Angelicae Sinensis grind into powder, as medicated powder after sieving;
C, pure water is used to decoct in the Radix Rehmanniae, as decoction liquor;
D, described medicated powder added in decoction liquor decoct, as material liquid;
E, until described material liquid in the pasty state time, carry out receipts cream, vacuum drying, pulverization process successively, obtain granular pharmaceutical composition.
5. preparation method according to claim 4, is characterized in that, the operation decocting distillation in step a repeats three times, and the distillate of three gained gathers and mix homogeneously; Each mass ratio decocting raw material and the pure water used in distillation is 1:6-9.
6. preparation method according to claim 5, is characterized in that, the raw material in step a, before carrying out first time decoction distillation, first uses pure water to soak 3-5 hour.
7. preparation method according to claim 4, is characterized in that, in step c, the mass ratio of the Radix Rehmanniae and pure water is 1:10-15, and decocting time is 4-8 hour; Powder described in step b crosses 80-100 mesh sieve.
8. preparation method according to claim 4, is characterized in that, the particle diameter of described granular pharmaceutical composition is 200-280 μm.
9. preparation method according to claim 4, is characterized in that, boils in process in steps d, adds 3-5 part Mel.
10. the application of the arbitrary described pharmaceutical composition of claim 1-3 in preparation treatment blood stasis medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510763129.2A CN105250481A (en) | 2015-11-10 | 2015-11-10 | Medicine composition for treatment of blood stasis and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510763129.2A CN105250481A (en) | 2015-11-10 | 2015-11-10 | Medicine composition for treatment of blood stasis and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105250481A true CN105250481A (en) | 2016-01-20 |
Family
ID=55090611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510763129.2A Pending CN105250481A (en) | 2015-11-10 | 2015-11-10 | Medicine composition for treatment of blood stasis and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105250481A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687589A (en) * | 2016-03-03 | 2016-06-22 | 孙世成 | Chinese medicine for treating clinical wound and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897814A (en) * | 2009-12-16 | 2010-12-01 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating acquired immune deficiency syndrome |
| CN104800269A (en) * | 2015-05-19 | 2015-07-29 | 北京市中医研究所 | Traditional Chinese medicine external-use cream used for treating psoriasis and preparation method thereof |
-
2015
- 2015-11-10 CN CN201510763129.2A patent/CN105250481A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897814A (en) * | 2009-12-16 | 2010-12-01 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating acquired immune deficiency syndrome |
| CN104800269A (en) * | 2015-05-19 | 2015-07-29 | 北京市中医研究所 | Traditional Chinese medicine external-use cream used for treating psoriasis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 刘毅波: "血瘀证的病理及活血化瘀中药的临床应用", 《天津中医药》 * |
| 张万水等: "血瘀证辨证治疗规律及用药规律研究概况", 《辽宁中医学院学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687589A (en) * | 2016-03-03 | 2016-06-22 | 孙世成 | Chinese medicine for treating clinical wound and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102000175B (en) | Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof | |
| CN103432390A (en) | Medicament for treating coronary heart disease and preparation method thereof | |
| CN106377599A (en) | Trollflower chewing gum and preparation method thereof | |
| CN102552537B (en) | Chinese medicinal composition for treating qi and blood loss | |
| CN102293964B (en) | Medicine for treating gastric ulcer, and preparation method thereof | |
| CN109718353A (en) | The traditional Chinese medicine pill and preparation method thereof for treating constipation | |
| CN102805834B (en) | Drug for curing gastritis and preparation method thereof | |
| CN105250481A (en) | Medicine composition for treatment of blood stasis and preparation method and application thereof | |
| CN105250966A (en) | Foot bath medicine for treatment of yang deficiency and preparation method and application thereof | |
| CN106177542A (en) | The Chinese prescription of a kind of summer heat clearing toxin resolving and goods thereof | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN102139083A (en) | Formula of medicament for treating cholecystitis and urolithiasis | |
| CN104984237A (en) | Traditional Chinese medicine composition and preparation method | |
| CN104587281A (en) | Spleen invigoration and diuresis promoting traditional Chinese medicine composition for treating cirrhosis and preparation | |
| CN103381234A (en) | Traditional Chinese medicine composition for curing chronic bronchitis and preparation method thereof | |
| CN103656459B (en) | A kind of Chinese medicine for the treatment of deficiency of both lung and spleen syndrome cough | |
| CN101653583A (en) | Medicine for treating hepatitis and production method thereof | |
| CN105250816A (en) | Medicine composition for treating phlegmatic hygrosis and preparation method and application of medicine composition | |
| CN105079319A (en) | Prescription for treating sciatica | |
| CN105106799A (en) | Prescription for treating ovarian cancer and preparation method | |
| CN105434874A (en) | Medicine for treating epifolliculitis and preparation method of medicine | |
| CN104857383B (en) | A kind of pharmaceutical composition for treating dental caries periapical inflammation and its application | |
| CN105148164A (en) | Antai Buqi Chinese herbal medicament for livestock | |
| CN104940703A (en) | Medicine for treating hematemesis and preparation method thereof | |
| CN104189514A (en) | Lymphatic tuberculosis resolving hard lump and eliminating phlegm preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160120 |
|
| RJ01 | Rejection of invention patent application after publication |